Ares to acquire most of America's freestanding veterinary hospitals; Regulator slams Antech's advertisement over heartworm screen;

> A private equity fund of Ares Management ($ARES) will acquire the parent company of National Veterinary Associates, the largest private owner of independent freestanding veterinary hospitals in the U.S. Release

> Ex-Merial vice president Dennis Steadman joined Greensboro, NC-based Piedmont Pharma, which develops both animal health and human therapeutics, bringing 35 years of experience to the company. Article

> Ceva Animal Health has returned to double-digit growth during the first half of 2014, the company reports, with its revenue shooting up 18.3% compared to the same period last year. Release

> The National Advertising Division has supported Idexx Laboratories' ($IDXX) allegations that rival pet diagnostics manufacturer Antech made false claims regarding its screening test for canine heartworm and tick-borne illnesses. Item

> The Colorado Department of Agriculture's State Veterinarian's Office is taking measures against an outbreak of vesicular stomatitis in horses by putting 7 of the affected areas under quarantine. Article

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…